CIRM has funded the ALS Disease Team led by scientists at UC San Diego, The Salk Institute, and Life Technologies Corporation, who aim to bring a human embryonic stem cell-based ALS therapy to clinical trials within four years. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, is a progressive motor neuron disorder. Most people with ALS die within 3 to 5 years from the onset of symptoms.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?